Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Change-In-Working-Capital" stands at -7.93 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025, the highest value since 03/31/2024.
Kyowa Kirin Co Ltd's second quarter result of 12.18 Billion JPY for the item "Change In Working Capital" represents an increase of 266.26 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 12.18 Billion JPY for the item "Change In Working Capital" represents an increase of 345.76 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of -7.93 Billion JPY for the item "Change In Working Capital" represents an increase of 68.37 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.83 Billion Japanese Yens compared to the value the year prior.
The 1 year change is 9.83 Billion Japanese Yens.
The 3 year change is -24.24 Billion Japanese Yens.
The 5 year change is -15.09 Billion Japanese Yens.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Change In Working Capital | 905,699,262,464.00 |
![]() | Johnson & Johnson - Change In Working Capital | 486,508,953,600.00 |
![]() | AbbVie Inc - Change In Working Capital | 399,570,305,024.00 |
![]() | Roche Holding AG - Change In Working Capital | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Change In Working Capital | 280,205,508,085.11 |